Results from this first use of the drug for this condition warrants testing the drug in a clinical trial.News Published: May 20, 2024 | Original story from Massachusetts General Hospital Read time: 2 minutesA team led by investigators from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, used a new...
Tag: <span>Blood clotting</span>
Post
FDA approves Takeda’s new enzyme replacement therapy for rare blood clotting disorder
Christophe Weber, Takeda CEO Shoko TakayasuNovember 9, 2023FDA approves Takeda’s new enzyme replacement therapy for rare blood clotting disorderZachary BrennanSenior EditorThe FDA on Thursday approved Takeda’s Adzynma, an enzyme replacement therapy for adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), which is a rare and potentially fatal blood clotting disorder. The approval was...
Post
Novel regulatory mechanism of blood clotting discovered
UNIVERSITY OF WÜRZBURG IMAGE: TREATMENT WITH SOLUBLE GPV PREVENTS THE FORMATION OF A VESSEL-OCCLUDING THROMBUS IN AN EXPERIMENTAL MOUSE MODEL OF THROMBOSIS FORMATION (RIGHT). ON THE LEFT, A VESSEL-OCCLUDING THROMBUS OF AN UNTREATED MOUSE IS SHOWN. CREDIT: SARAH BECK / RUDOLF-VIRCHOW CENTER WUERZBURG When our blood vessels are injured by cuts, abrasions, or bruises, it...
Post
Blood clotting may be the root cause of long COVID syndrome
by RCSI University of Medicine and Health Sciences Figure 1. Credit: DOI: 10.1111/jth.15490 New evidence shows that patients with long COVID syndrome continue to have higher measures of blood clotting, which may help explain their persistent symptoms, such as reduced physical fitness and fatigue. The study, led by researchers from RCSI University of Medicine and Health Sciences,...
Post
Treatment of rare cases of blood clotting in brain following COVID-19 vaccination
by University College London Left: CT venogram showing a filling defect in the sagittal sinus (black arrow). Right: A dural venous sinus thrombosis of the transverse sinus. Greater on the right than left. Credit: wikimediacommons A new UCL and UCLH-led study of patients with cerebral venous thrombosis (CVT) following COVID-19 vaccination, provides a clearer guide for...
Post
A breakthrough in the physics of blood clotting
by Georgia Institute of Technology First author Yueyi Sun inside Georgia Tech’s Complex Fluids Modeling and Simulation lab, where she compares the experimental and simulated platelet-driven fibrin clot contraction process. Credit: Alexander Alexeev, Georgia Tech Heart attacks and strokes—the leading causes of death in human beings—are fundamentally blood clots of the heart and brain. Better understanding...
Post
What to know about the warfarin diet
People taking the blood thinning medication warfarin may need to moderate vitamin K levels in their diets. Vitamin K may interfere with the effectiveness of warfarin. A doctor may prescribe warfarin to someone who has had a blood clot in the past, as they are at a higher risk of blood clots in the future....
Post
Researchers show dietary choline and TMAO linked with increased blood clotting
Cleveland Clinic researchers have shown, for the first time in humans, that choline is directly linked to increased production of a gut bacteria byproduct that increases the risk of blood-clotting events like heart attack and stroke. However, the research also showed that adding a low dose of aspirin may reduce that risk. In a small...
Post
Smart plaster that tells doctors how you feel: Tiny sensors within bandages will detect infections and blood clotting before reporting back to medics
Smart bandages can now detect how well a wound is healing and let you know Sensors are fitted into dressings that can spot infections, pick up blood clotting The plaster could also connect to a smartphone to track other health concerns Smart bandages that can detect how well a wound is healing and send messages...
Post
After one dose of gene therapy, hemophilia B patients maintain near-normal levels of clotting factor
Researchers are reporting the highest and most sustained levels to date of an essential blood-clotting factor IX in patients with the inherited bleeding disorder hemophilia B. After receiving a single dose of an experimental gene therapy in a clinical trial, patients with hemophilia produced near-normal levels of clotting factor IX, allowing them to stop clotting...